MRTX849

99%

  • Product Code: 108953
  CAS:    2326521-71-3
Molecular Weight: 604.12 g./mol Molecular Formula: C₃₂H₃₅ClFN₇O₂
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: -20°C, airtight, dry
Product Description: MRTX849 is primarily used in the treatment of cancers with specific genetic mutations. It is a targeted therapy designed to inhibit the activity of mutated KRAS proteins, particularly the KRAS G12C mutation, which is commonly found in certain types of lung, colorectal, and pancreatic cancers. By blocking this mutation, MRTX849 helps to slow down or stop the growth of cancer cells. It is often administered orally and is being studied in clinical trials to evaluate its effectiveness, either as a standalone treatment or in combination with other therapies. Its development represents a significant advancement in precision medicine for patients with KRAS-driven cancers.
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.010 10-20 days ฿143,000.00
+
-
MRTX849
MRTX849 is primarily used in the treatment of cancers with specific genetic mutations. It is a targeted therapy designed to inhibit the activity of mutated KRAS proteins, particularly the KRAS G12C mutation, which is commonly found in certain types of lung, colorectal, and pancreatic cancers. By blocking this mutation, MRTX849 helps to slow down or stop the growth of cancer cells. It is often administered orally and is being studied in clinical trials to evaluate its effectiveness, either as a standalone treatment or in combination with other therapies. Its development represents a significant advancement in precision medicine for patients with KRAS-driven cancers.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: ฿0.00
฿0.00 Total :